Filter Results:
(233)
Show Results For
- All HBS Web
(1,032)
- People (4)
- News (233)
- Research (609)
- Events (7)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(1,032)
- People (4)
- News (233)
- Research (609)
- Events (7)
- Multimedia (24)
- Faculty Publications (398)
Sort by
- 01 Jun 2018
- News
Floor It
case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform trial, different View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 01 Dec 2013
- News
To Market, to Market
chirality) of drug molecules with a high degree of accuracy for drug development and diagnostic applications. Chemical compounds excreted by predators that stimulate avoidance behavior in disease-carrying... View Details
- 01 Dec 2001
- News
Reaching Out
Ph.D. in pathology and molecular biology at Boston University's School of Medicine. Intrigued by his experience with pharmaceutical companies and the role of business in drug delivery, he enrolled at HBS one month after finishing his... View Details
- 01 Dec 2010
- News
This Is What I Do
to be police officers. “These girls are money,” says the director of a shelter in Kabul, Afghanistan, as she tells a visitor about one of her charges, an 11-year-old girl named Obaida, sold by her father into marriage to support his drug... View Details
- 04 Sep 2019
- News
Deep Dive
ship to launch and recover the submersible. He found a decommissioned US Navy ship laid up in a river in Washington State. The USNS Indomitable was originally built to hunt Soviet submarines at the end of the Cold War and was then used by the US Coast Guard for View Details
- 01 Mar 2013
- News
Opening the Door
neighborhood-based health plan for the city of Charlestown, and I became involved in building a system of benchmarks for the various services that were being offered—everything from dental care to drug and alcohol abuse counseling. I... View Details
- 01 Mar 2008
- News
The Last Frontier
state for people with debilitating but nonterminal diseases like his to receive, with a doctor’s assistance, drugs with which they may take their own lives. Explained Gardner, “Why do this? I want to be involved in public life. I was... View Details
- 01 Jun 2003
- News
Against All Odds
never accomplished by any other European country, despite 150 years of trying). If it sounds almost as difficult as bringing a profitable drug to market, maybe that’s why Ernesto Bertarelli (MBA ’93), CEO of the Swiss biotech company... View Details
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the development of... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand the anguish of seriously ill... View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
investment in math and physical sciences. Moving on to challenges Merck has faced, Gilmartin explained that new drug discovery tools have increased the speed at which its competitors can introduce new products to the marketplace, even as... View Details
- 08 Mar 2017
- News
Safe, Secure, and Prosperous
protect our nation by stopping all of the threats that might affect us: national security, criminality, human trafficking, and illicit drugs crossing our borders. “The job that I have has responsibility for the intelligence capability and... View Details
- 01 Jun 2016
- News
@Soldiers Field
diverse, outstanding future leaders and who will go on to make a real difference in the world.” Baker Library’s Historical Collections acquired a trove of archival materials from Genzyme, one of the world’s leading biotechnology firms. A pioneer in the development of... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients who, until now, had few options beyond prescription drugs to help lessen the... View Details
Keywords: Janelle Nanos
- 01 Mar 2017
- News
Alumni Take Cold Calls in New York City
focused on 23andMe, whose sale of genetic testing kits directly to consumers was challenged by the Food & Drug Administration. Quelch, who coauthored the case, is also on the faculty of the Harvard T.H. Chan School of Public Health. The... View Details
- 01 Mar 2009
- News
Model Patient
care, plus some drug coverage — was rejected. It smacked of a “two-tiered” system, he says, and was unacceptable for political reasons. Costs have thus been significantly higher than expected because the standard plan — with a relatively... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
health information network are expected to be substantial. A RAND Corporation study estimates savings to the U.S. health-care system of up to $162 billion a year by improving medical-care delivery, reducing medical errors and adverse drug... View Details
- 03 Mar 2017
- News
Big Blue’s Big Bet
of the UNC Lineberger Comprehensive Cancer Center. Besides reading all the medical journals, Watson could inform doctors of when certain drug trials began and when others ended; it could also sequence a genome and find important gene... View Details
Keywords: Paul Kix; illustrations by Dan Page
- 01 Dec 2006
- News
Faculty Books
from its character as a science-based business. This poses three challenges: how to finance risky investments with long time horizons for R&D; keep pace with advances in drug knowledge; and integrate capabil-ities across the spectrum of... View Details